Astrazeneca Pharma India Ltd

Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products.(Source : 201903 Annual Report Page No: 72)

  • Market Cap: 7,943 Cr.
  • Current Price: 3,177
  • 52 weeks High / Low 3375.00 / 1632.55
  • Book Value: 145.78
  • Stock P/E: 109.98
  • Dividend Yield: 0.03 %
  • ROCE: 26.51 %
  • ROE: 19.87 %
  • Sales Growth (3Yrs): 8.91 %
  • Listed on BSE and NSE
  • Company Website
  • Face Value: 2.00
Edit ratios
Pros:
Company is virtually debt free.
Company has good consistent profit growth of 39.13% over 5 years
Cons:
Stock is trading at 21.79 times its book value
The company has delivered a poor growth of 8.98% over past five years.
Company has a low return on equity of 13.76% for last 3 years.

Peer comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Multinational

Loading peers table ...

Quarterly Results Figures in Rs. Crores

Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020
127 164 129 151 161 161 215 190 205 208 224 195
121 129 139 135 152 147 174 184 169 175 187 180
Operating Profit 6 36 -11 15 9 15 41 6 36 34 37 15
OPM % 5% 22% -8% 10% 6% 9% 19% 3% 17% 16% 16% 8%
Other Income 5 2 3 2 3 3 4 6 3 3 3 3
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 4 4 4 4 4 4 4 5 5 5 5
Profit before tax 7 34 -12 14 9 14 41 8 34 32 35 13
Tax % 19% 20% 12% 77% 30% 37% 28% -16% 36% 55% 24% 28%
Net Profit 6 27 -10 3 6 9 29 10 22 14 27 10
EPS in Rs 2.32 10.95 -4.14 1.29 2.58 3.65 11.64 3.93 8.61 5.77 10.68 3.83
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
302 353 397 594 531 390 474 517 564 544 571 728 832
211 241 307 490 501 459 487 528 547 507 525 657 711
Operating Profit 92 113 90 104 30 -68 -13 -11 16 37 46 71 121
OPM % 30% 32% 23% 17% 6% -18% -3% -2% 3% 7% 8% 10% 15%
Other Income 10 14 5 6 6 10 23 6 7 14 12 16 13
Interest 0 5 0 0 0 0 0 0 0 0 0 0 1
Depreciation 6 7 6 9 7 12 10 15 17 16 15 15 19
Profit before tax 95 114 88 101 29 -70 0 -21 6 36 44 73 114
Tax % 36% 35% 35% 36% 32% -27% -0% 9% 44% 41% 25%
Net Profit 61 74 58 64 20 -90 -1 -21 5 20 26 54 72
EPS in Rs 22.04 26.99 21.35 19.25 7.34 0.00 0.00 0.00 2.10 8.02 10.36 21.78 28.89
Dividend Payout % 61% 51% 43% 39% 44% -0% -0% -0% 0% 0% 0% 0%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:7.50%
5 Years:8.98%
3 Years:8.91%
TTM:14.21%
Compounded Profit Growth
10 Years:-3.03%
5 Years:39.13%
3 Years:118.44%
TTM:32.68%
Stock Price CAGR
10 Years:13.62%
5 Years:27.83%
3 Years:51.33%
1 Year:70.97%
Return on Equity
10 Years:6.25%
5 Years:7.94%
3 Years:13.76%
Last Year:19.87%

Balance Sheet Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
5 5 5 5 5 5 5 5 5 5 5 5 5
Reserves 154 111 140 175 184 95 167 146 151 218 242 296 359
Borrowings 0 62 0 0 0 0 0 0 0 0 0 0 12
87 110 89 129 156 206 244 261 247 193 214 261 330
Total Liabilities 246 288 234 309 345 306 416 412 403 415 461 562 706
33 30 30 27 32 25 94 101 97 87 75 75 72
CWIP 0 0 0 24 58 74 9 12 6 5 4 7 24
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
213 258 204 257 255 208 312 298 299 324 382 480 611
Total Assets 246 288 234 309 345 306 416 412 403 415 461 562 706

Cash Flows Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
40 82 33 64 39 -6 -1 -46 57 38 9 55
-3 5 2 -28 -34 -16 -15 -19 -4 0 -9 4
-34 -54 -111 -29 -29 -10 86 0 -1 0 0 0
Net Cash Flow 3 33 -76 8 -24 -32 71 -64 53 38 -1 59

Ratios Figures in Rs. Crores

Dec 2007 Dec 2008 Dec 2009 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 63% 71% 55% 62% 15% -53% -12% -13% 4% 15% 19% 27%
Debtor Days 57 52 63 27 22 26 41 30 54 29 35 40
Inventory Turnover 3.27 3.44 3.50 3.88 2.70 1.93 1.83 2.20 2.44 2.59 2.11 2.00